AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 8123947
Drug: Heparin 500
RxNorm normalized name: HEPARIN 5000 UNT/ML SYRINGE 1ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin 500 units and Hydrocortisone 10 mg/L
Trial: 8123947
Drug: In-line filter
RxNorm normalized name: Gallus gallus gizzard lining preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: In-line filter with drug-free infusate
Trial: 8123947
Drug: Long intravenous
RxNorm normalized name: long pepper extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long intravenous catheters (30 cm)
Trial: 8123947
Drug: Short intravenous
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short intravenous catheters
Trial: 2700316
Drug: Whole liver
RxNorm normalized name: LIVER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole liver radiation therapy (RT) alone
Trial: 2700316
Drug: Whole liver
RxNorm normalized name: LIVER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole liver radiation therapy (RT) combined with chemotherapy (systemic and/or intra-hepatic)
Trial: 2700316
Drug: Innovative techniques
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Innovative techniques of delivering RT (intraoperative brachytherapy, radiolabeled antibodies, hyperfractionated external beam RT)
Trial: 15726550
Drug: Paracetamol up
RxNorm normalized name: Q-Up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol up to 3 g/d
Trial: 15726550
Drug: Aspirin up
RxNorm normalized name: Q-Up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin up to 3 g/d
Trial: 15726550
Drug: Ibuprofen up
RxNorm normalized name: Q-Up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen up to 1200 mg/d
Trial: 12238905
Drug: Terbutaline (Bricanyl,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbutaline (Bricanyl, 5.0 mg/2ml)
Trial: 12238905
Drug: Fenoterol (Berotec,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenoterol (Berotec, 1.25 mg/2ml)
Trial: 9620106
Drug: Antifungal prophylaxis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antifungal prophylaxis (systemic, intranasal, lipid formulations of amphotericin B, fluconazole, itraconazole)
Trial: 7865418
Drug: Rubber dam
RxNorm normalized name: Aspergillus ruber
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rubber dam isolation and mechanical preparation of pits and fissures using a round bur No. 0 in a slow hand‐piece
Trial: 7865418
Drug: Cotton rolls
RxNorm normalized name: Cotton
DrugBank: Cotton (DB10707)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cotton rolls isolation and mechanical preparation of pits and fissures using a round bur No. 0 in a slow hand‐piece
Trial: 31289040
Drug: Nivolumab and
RxNorm normalized name: nivolumab and relatlimab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nivolumab and ipilimumab (perioperative immunotherapy)
Trial: 28682837
Drug: Semiautonomous (decision
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Semiautonomous (decision assist) fluid administration
Trial: 22848080
Drug: Blockade day
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blockade day (combined oral H(1) and H(2) receptor antagonism with fexofenadine and ranitidine)
Trial: 19226297
Drug: Intravenous fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous fentanyl (Group Fv)
Trial: 12486749
Drug: Selective exclusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selective exclusion of treatment arms in multi-arm randomized clinical trials
Trial: 9987698
Drug: Modafinil 600
RxNorm normalized name: Modafinil
DrugBank: Modafinil (DB00745)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Modafinil 600 mg
Trial: 9987698
Drug: Modafinil 800
RxNorm normalized name: Modafinil
DrugBank: Modafinil (DB00745)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Modafinil 800 mg
Trial: 8749241
Drug: Domperidone 20
RxNorm normalized name: Domperidone
DrugBank: Domperidone (DB01184)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domperidone 20 mg orally
Trial: 8749241
Drug: Metoclopramide 20
RxNorm normalized name: metoclopramide 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoclopramide 20 mg as suppository or 10‐20 mg orally
Trial: 8749241
Drug: 1,000 mg
RxNorm normalized name: bran 1,000 mg ORAL WAFER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,000 mg acetylsalicylic acid as effervescent tablets
Trial: 8749241
Drug: 1,000 mg
RxNorm normalized name: bran 1,000 mg ORAL WAFER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,000 mg paracetamol as effervescent tablets or suppositories
Trial: 8749241
Drug: Naproxen 500-1,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen 500-1,000 mg
Trial: 8749241
Drug: Ibuprofen 400-800
RxNorm normalized name: ibuprofen 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen 400-800 mg
Trial: 8749241
Drug: Standard reference
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard reference drugs
Trial: 2080867
Drug: Intranasal interferon
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal interferon alpha-2a
Trial: 7351286
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg prostaglandin E2 three times daily
Trial: 31811429
Drug: Induction chemotherapy
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction chemotherapy (IC) for patients with nodal grouping (NG) in stages N1 and N2
Trial: 31152080
Drug: Docetaxel (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Docetaxel (75 mg/m2 intravenously every 3 weeks) plus Prednisone (5 mg twice daily) plus Cediranib (30 mg once daily)
Trial: 31152080
Drug: Docetaxel (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Docetaxel (75 mg/m2 intravenously every 3 weeks) plus Prednisone (5 mg twice daily)
Trial: 19624286
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation containing PLC, L‐Arg and nicotinic acid (Ezerex)
Trial: 19624286
Drug: Vardenafil (Levitra)
RxNorm normalized name: vardenafil Oral Tablet [Levitra]
DrugBank: Vardenafil (DB00862)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vardenafil (Levitra) 20 mg twice a week
Trial: 19624286
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation plus vardenafil 20 mg twice a week
Trial: 19624286
Drug: Placebo capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo capsules twice weekly
Trial: 15291499
Drug: 100 mL
RxNorm normalized name: PVC IV Bag 100 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mL of fresh Sweetie juice
Trial: 15291499
Drug: 200 mL
RxNorm normalized name: Bag Top-Fill, 1200 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mL of fresh Sweetie juice
Trial: 9459232
Drug: ondansetron 4
RxNorm normalized name: ondansetron 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ondansetron 4 mg after surgery (Group D)
Trial: 9459232
Drug: ondansetron 4
RxNorm normalized name: ondansetron 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ondansetron 4 mg before induction (Group C)
Trial: 9459232
Drug: ondansetron 2
RxNorm normalized name: ondansetron 24 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ondansetron 2 mg at the start of and 2 mg after surgery (Group B)
Trial: 26137850
Drug: Herbal compound
RxNorm normalized name: BENZOIN COMPOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Herbal compound containing Malva sylvestris and Alcea digitata (Boiss)
Trial: 11404758
Drug: Gold alloy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gold alloy with chamfer finish line (group G)
Trial: 9423503
Drug: Routine Treatment
RxNorm normalized name: Peace Out Acne Hero Routine KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine Treatment (RT) group
Trial: 3115130
Drug: Sodium cromoglycate
RxNorm normalized name: Sodium cromoglycate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium cromoglycate (SCG) nasal spray
Trial: 3115130
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of sodium cromoglycate and hyposensitization
Trial: 29897544
Drug: 2-g LP
RxNorm normalized name: LP-20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2-g LP bar (11 g protein with 2 g added LP)
Trial: 29897544
Drug: 3-g LP
RxNorm normalized name: LP-20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3-g LP bar (13 g protein with 3 g added LP)
Trial: 29897544
Drug: 0-g LP
RxNorm normalized name: LP-20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0-g LP bar (9 g protein with 0 g added LP)
Trial: 22493913
Drug: Acupoint sticking
RxNorm normalized name: Zit Stick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupoint sticking therapy during dog days and the three nine‐day periods after the winter solstice (Group A)
Trial: 22493913
Drug: Acupoint sticking
RxNorm normalized name: Zit Stick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupoint sticking therapy during dog days (Group B)
Trial: 22493913
Drug: Acupoint sticking
RxNorm normalized name: Zit Stick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupoint sticking therapy during the three nine‐day periods after the winter solstice (Group C)
Trial: 15890634
Drug: Dextromethorphan (DEX)
RxNorm normalized name: Dextromethorphan
DrugBank: Dextromethorphan (DB00514)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dextromethorphan (DEX) 60 mg
Trial: 15890634
Drug: Dextromethorphan (DEX)
RxNorm normalized name: Dextromethorphan
DrugBank: Dextromethorphan (DB00514)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dextromethorphan (DEX) 90 mg
Trial: 12753447
Drug: Fentanyl 1
RxNorm normalized name: fentanyl 1.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 1 micro g.kg‐1 i.v.
Trial: 10593672
Drug: Methylprednisolone (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (1 mg/kg daily for 10 days orally)
Trial: 17712121
Drug: Sibutramine 10
RxNorm normalized name: sibutramine 10 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sibutramine 10 mg/d
Trial: 8732960
Drug: Sibutramine 15
RxNorm normalized name: sibutramine 15 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sibutramine 15 mg/d
Trial: 8732960
Drug: Sibutramine 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sibutramine 20 mg/d
Trial: 8732960
Drug: Sibutramine 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sibutramine 30 mg/d
Trial: 22344575
Drug: Methotrexate (MTX)
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate (MTX) 15 mg/week
Trial: 29036790
Drug: Endostar combined
RxNorm normalized name: Menostar
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Endostar combined with NP chemotherapy
Trial: 29036790
Drug: NP chemotherapy
RxNorm normalized name: NP Thyroid Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NP chemotherapy alone (Control)
Trial: 26445179
Drug: Decaffeinated coffee
RxNorm normalized name: Coffee bean
DrugBank: Coffee bean (DB10525)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Decaffeinated coffee (100 mL 3 times daily)
Trial: 26445179
Drug: Caffeinated coffee
RxNorm normalized name: Coffee bean
DrugBank: Coffee bean (DB10525)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeinated coffee (100 mL 3 times daily)
Trial: 26445179
Drug: Water (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Water (100 mL 3 times daily)
Trial: 19445546
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of CBT plus sertraline
Trial: 19445546
Drug: Fluvoxamine 25
RxNorm normalized name: fluvoxaMINE 25 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvoxamine 25 mg/day, Fluoxetine 10 mg/day, Sertraline 25 mg/day
Trial: 19445546
Drug: Pharmacotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacotherapy with systematic tracking of treatment-emergent adverse events
Trial: 19445546
Drug: Long-term medication
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term medication use
Trial: 15623680
Drug: Petasites extract
RxNorm normalized name: Petasites fragrans extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Petasites extract 75 mg bid
Trial: 15623680
Drug: Petasites extract
RxNorm normalized name: Petasites fragrans extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Petasites extract 50 mg bid
Trial: 9203933
Drug: Omeprazole 60
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole 60 mg/day for three days and 80 mg intravenous before perfusion
Trial: 9203933
Drug: Ranitidine 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 600 mg/day for three days and 50 mg/h intravenous during perfusion
Trial: 3308483
Drug: Single five-drug
RxNorm normalized name: fivehorn smotherweed pollen extract
DrugBank: Bassia hyssopifolia pollen (DB10941)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single five-drug combination (adriamycin 50 mg, vincristine 1.5 mg, 5-fluorouracil 750 mg intravenously; methotrexate 50 mg intramuscularly; chlorambucil 10 mg orally, followed by three doses of chlorambucil 10 mg at 6-h intervals)
Trial: 3308483
Drug: Alternating combinations
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternating combinations of two three-drug regimens (Regimen A: vincristine 1.5 mg, adriamycin 70 mg, methotrexate 50 mg; Regimen B: 5-fluorouracil 750 mg, vindesine 5 mg intravenously, cyclophosphamide 50 mg orally, followed by three doses of cyclophosphamide 50 mg at 6-h intervals)
Trial: 3308483
Drug: Both treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatment groups (single and alternating combinations)
Trial: 15170011
Drug: Treatment with
RxNorm normalized name: Campho-Phenique Cold Sore Treatment with Drying Action
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment with single dose (2 g) metronidazole and clotrimazole cream for 3 days, randomized to follow-up strategies
Trial: 15170011
Drug: Follow-up strategy
RxNorm normalized name: Q-Up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Follow-up strategy B: Come back on day 7 regardless of response to treatment
Trial: 9660431
Drug: Leuprolide acetate
RxNorm normalized name: Leuprolide Acetate
DrugBank: Leuprolide (DB00007)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leuprolide acetate (3.75 mg every 28 days IM) + placebo tablets (group A)
Trial: 9660431
Drug: Leuprolide acetate
RxNorm normalized name: Leuprolide Acetate
DrugBank: Leuprolide (DB00007)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leuprolide acetate (3.75 mg every 28 days IM) + 2.5 mg of tibolone per os (group B)
Trial: 7640448
Drug: Prophylactic portal
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic portal infusion chemotherapy (PPIC)
Trial: 782700
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of BCNU, vinblastine, cyclophosphamide, procarbazine, and prednisone
Trial: 782700
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)
Trial: 21862829
Drug: Opioid blockade
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Opioid blockade (8 mg of naloxone)
Trial: 19696704
Drug: 200 microg
RxNorm normalized name: Digoxin 200 microgram oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 microg oral transmucosal fentanyl citrate
Trial: 9766793
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human erythropoietin (40 IU kg(‐1)i.v., three times weekly)
Trial: 6179
Drug: Practolol (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Practolol (250 mg)
Trial: 6179
Drug: Tolamolol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolamolol (100 mg)
Trial: 6179
Drug: Tolamolol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolamolol (200 mg)
Trial: 10479194
Drug: 6.6 g
RxNorm normalized name: FERROUS SULFATE 76.6 g in 454 g TOPICAL POWDER [Hemostat]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6.6 g n‐3 PUFA
Trial: 10479194
Drug: 2.0 g
RxNorm normalized name: Fifty50 2.0 Glucose Meter
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.0 g n‐3 PUFA
Trial: 1649840
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of estrogen alone
Trial: 1649840
Drug: Percutaneous administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Percutaneous administration of estrogen
Trial: 1649840
Drug: Utrogestan in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Utrogestan in combination with oral estrogen
Trial: 6359083
Drug: Propiram fumarate
RxNorm normalized name: fumarate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propiram fumarate 50 mg
Trial: 354840
Drug: Codeine sulfate
RxNorm normalized name: Codeine Sulfate
DrugBank: Codeine (DB00318)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Codeine sulfate 60 mg
Trial: 30262155
Drug: Treatment with
RxNorm normalized name: Campho-Phenique Cold Sore Treatment with Drying Action
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment with T4 normalization after 5 months (median and percentiles 2.0-10.5 months)
Trial: 14595048
Drug: Diphtheria-tetanus-acellular pertussis
RxNorm normalized name: acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diphtheria-tetanus-acellular pertussis vaccine (DTaP)
Trial: 14595048
Drug: Diphtheria-tetanus vaccine
RxNorm normalized name: diphtheria toxoid vaccine, inactivated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diphtheria-tetanus vaccine only (DT)
Trial: 8804804
Drug: 400 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 micrograms oral misoprostol
Trial: 1615883
Drug: dF 15
RxNorm normalized name: Adriamycin RDF 150mg Powder for Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dF 15 mg twice daily for 26 weeks
Trial: 6151206
Drug: Divided dosage
RxNorm normalized name: osage orange pollen extract
DrugBank: Maclura pomifera pollen (DB10988)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Divided dosage (DD) of prazepam 40 mg per day (10 mg in the morning, 10 mg at noon, 20 mg in the evening)
Trial: 6151206
Drug: Single dosage
RxNorm normalized name: osage orange pollen extract
DrugBank: Maclura pomifera pollen (DB10988)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dosage (SD) of prazepam 40 mg per day (40 mg in the evening)
Trial: 29738057
Drug: TAP block
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAP block with 30 mL 0.25% levobupivacaine
Trial: 29738057
Drug: Local anesthetic
RxNorm normalized name: Local anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local anesthetic infiltration with 20 mL of levobupivacaine 0.5%
Trial: 21034545
Drug: Vital capacity
RxNorm normalized name: Vital-Chlor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vital capacity induction with 8% sevoflurane at 6 L/min
Trial: 21034545
Drug: Tidal breathing
RxNorm normalized name: cetylpyridinium chloride Mouthwash [Breath-Away]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tidal breathing induction with 8% sevoflurane at 6 L/min
Trial: 1792400
Drug: Etomidate 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etomidate 0.3 mg/kg
Trial: 1968919
Drug: Cetirizine 20
RxNorm normalized name: cetirizine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetirizine 20 mg (three daily doses)
Trial: 1968919
Drug: Cetirizine (5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetirizine (5, 10, and 20 mg)
Trial: 1968919
Drug: Cetirizine and
RxNorm normalized name: Cetirizine and pseudoephedrine only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetirizine and Albuterol
Trial: 1968919
Drug: Albuterol 4
RxNorm normalized name: albuterol 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol 4 mg
Trial: 395955
Drug: Nicergoline (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicergoline (3 x 1 dragée at 10 mg for 12 weeks)
Trial: 30288999
Drug: automated closed-loop
FDA approved: no
EMA approved: no
PMDA approved: no
Description: automated closed-loop therapy
Trial: 30288999
Drug: sensor-augmented pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sensor-augmented pump therapy
Trial: 20965155
Drug: Length of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Length of hormone therapy (HT) use
Trial: 2882420
Drug: Coronary‐artery bypass
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coronary‐artery bypass surgery plus medical therapy
Trial: 26545320
Drug: Antiplatelet or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiplatelet or anticoagulant drugs
Trial: 26545320
Drug: No antiplatelet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No antiplatelet or anticoagulant drugs
Trial: 20128041
Drug: Feiji Recipe
RxNorm normalized name: SALICYLIC ACID 1 g in 100 mL TOPICAL SHAMPOO [Maetria Miracle Recipe PremiumShampoo]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Feiji Recipe combined with chemotherapy